Global Generic Drugs Market 2016-2020

SKU ID : TNV- 10279065

Publishing Date : 26-May-2016

No. of pages : 111


  • About the Generic Drugs Market

    Generic drugs have the same chemical formula, dosage form, potency, route of administration, quality, and intended use as that of patented branded drugs. They cost 80%-85% lesser than their branded counterparts and are available soon after the patent expiries of original drugs. However, they are similar to original drugs in terms of safety, quality, and effectiveness. Manufacturers need to apply for an Abbreviated New Drug Application (ANDA) approval to receive approval of generics.

    Technavio’s analysts forecast the global generic drugs market to grow at a CAGR of 10.53% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global generic drugs market for 2016-2020. To calculate the market size, it considers revenue generated from the sales of simple generics, super generics, and biosimilars.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Generic Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Teva Pharmaceuticals
    • Sandoz
    • Allergan
    • Mylan
    • Sun Pharmaceuticals
    • STADA Arzneimittel

    Other prominent vendors
    • Abbott
    • Amgen
    • Apotex
    • Aspen
    • AstraZeneca
    • Aurobindo Pharma
    • Baxter
    • Berlin-Chemie
    • Biocon
    • Biogen
    • Boehringer Ingelheim
    • Celltrion
    • Cipla
    • Coherus Biosciences
    • Dr. Reddy's Laboratory
    • Daiichi Sankyo
    • Eli Lilly
    • Emcure Pharmaceuticals
    • Eurofarma Laboratories
    • Gedeon Richter
    • Gilead Sciences
    • GlaxoSmithKline
    • Hospira
    • Impax
    • InnoPharma
    • Intas Pharmaceuticals
    • Jannsen
    • Lupin
    • Merck
    • Mitsubishi Tanabe Pharma
    • Momenta Pharmaceuticals
    • Natco Pharma
    • Nexus Pharmaceuticals
    • Novo Nordisk
    • Orchid Chemicals & Pharmaceuticals
    • Parenteral Drugs India
    • Par Pharmaceutical
    • Pfizer
    • Piramal (Abbott Laboratories)
    • Roche Holdings
    • Sanofi
    • Synthon
    • Towa
    • Valeant Pharmaceuticals
    • Zentiva
    • Zhejiang Chira Medicine Chemicals
    • Zhejiang Hisun Pharmaceutical
    • Zydus Cadila Healthcare

    Market driver
    • Patent expiry of top-selling drugs
    • For a full, detailed list, view our report

    Market challenge
    • Threat of counterfeit drugs
    • For a full, detailed list, view our report

    Market trend
    • Outsourcing of drug development activities
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions

    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports